Biotech · Private company
Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company
Track this companyFree. Adds Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- [14C]-STX-478Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- LY4064809Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- TersolisibPhase 1 · Renal InsufficiencyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of Tersolisib (LY4064809) in Participants With Kidney Impairment Compared With Participants With Normal Kidney FunctionPHASE1 · NOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07924930 · fetched Nov 12, 2026
- A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult ParticipantsPHASE1 · COMPLETED · started May 20, 2025ClinicalTrials.gov NCT06991179 · fetched Nov 12, 2026
- A Study of LY4064809 [14C]-STX-478 in Healthy Male ParticipantsPHASE1 · COMPLETED · started Mar 20, 2025ClinicalTrials.gov NCT06901336 · fetched Nov 12, 2026